294 related articles for article (PubMed ID: 15746655)
21. [An important source of error in Rh(D) typing].
Heier HE; Kornstad L; Volle G
Tidsskr Nor Laegeforen; 1987 Apr; 107(12):1024-6. PubMed ID: 3037723
[No Abstract] [Full Text] [Related]
22. Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis.
Clausen FB; Rieneck K; Krog GR; Bundgaard BS; Dziegiel MH
Methods Mol Biol; 2019; 1885():347-359. PubMed ID: 30506209
[TBL] [Abstract][Full Text] [Related]
23. Non-invasive prenatal determination of fetal RhD genotyping from maternal plasma: a preliminary study in Pakistan.
Mohammed N; Kakal F; Somani M; Zafar W
J Coll Physicians Surg Pak; 2010 Apr; 20(4):246-9. PubMed ID: 20392400
[TBL] [Abstract][Full Text] [Related]
24. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy.
Costa JM; Giovangrandi Y; Ernault P; Lohmann L; Nataf V; El Halali N; Gautier E
Br J Haematol; 2002 Oct; 119(1):255-60. PubMed ID: 12358932
[TBL] [Abstract][Full Text] [Related]
25. [Noninvasive prenatal diagnosis from maternal plasma in serological conflicts in Poland: current practice and future prospects].
Orzińska A; Guz K; Brojer E
Ginekol Pol; 2009 Oct; 80(10):768-71. PubMed ID: 19943542
[TBL] [Abstract][Full Text] [Related]
26. [Examination of the RHD gene by non-invasive method in plasma of alloimmunized mother allowed to abandon invasive procedures and to deliver a healthy child].
Orzińska A; Guz K; Brojer E; Zupańska B
Ginekol Pol; 2004 Dec; 75(12):963-5. PubMed ID: 15751219
[TBL] [Abstract][Full Text] [Related]
27. [Non-invasive fetal RhD typing and RhD negative pregnant women--preliminary observations].
Guz K; Brojer E; Zupańska B; Orzińska A; Kalińska A; Bec JR
Ginekol Pol; 2004 Jan; 75(1):21-5. PubMed ID: 15112469
[TBL] [Abstract][Full Text] [Related]
28. Specific magnetic bead-based capture of free fetal DNA from maternal plasma.
Legler TJ; Liu Z; Heermann KH; Hempel M; Gutensohn K; Kiesewetter H; Pruss A
Transfus Apher Sci; 2009 Jun; 40(3):153-7. PubMed ID: 19364676
[TBL] [Abstract][Full Text] [Related]
29. Partial D in an obstetrical patient presenting as a mixed field on Rh typing.
Pavenski K; Krok E; Anderson M; Krzyzanowski B
Transfusion; 2017 Sep; 57(9):2074-2075. PubMed ID: 28868743
[No Abstract] [Full Text] [Related]
30. How do I manage Rh typing in obstetric patients?
Haspel RL; Westhoff CM
Transfusion; 2015 Mar; 55(3):470-4. PubMed ID: 25647404
[No Abstract] [Full Text] [Related]
31. Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: an investigation into the preferences and information needs of women.
Oxenford K; Silcock C; Hill M; Chitty L
Prenat Diagn; 2013 Jul; 33(7):688-94. PubMed ID: 23625761
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.
de Haas M; Thurik FF; van der Ploeg CP; Veldhuisen B; Hirschberg H; Soussan AA; Woortmeijer H; Abbink F; Page-Christiaens GC; Scheffer PG; Ellen van der Schoot C
BMJ; 2016 Nov; 355():i5789. PubMed ID: 27821701
[TBL] [Abstract][Full Text] [Related]
33. Fetal blood group genotyping: present and future.
Daniels G; Finning K; Martin P; Summers J
Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
[TBL] [Abstract][Full Text] [Related]
34. Management of rhesus isoimmunization by preimplantation genetic diagnosis.
Avner R; Reubinoff BE; Simon A; Zentner BS; Friedmann A; Mitrani-Rosenbaum S; Laufer N
Mol Hum Reprod; 1996 Jan; 2(1):60-2. PubMed ID: 9238659
[TBL] [Abstract][Full Text] [Related]
35. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma.
Finning K; Martin P; Daniels G
Ann N Y Acad Sci; 2004 Jun; 1022():119-23. PubMed ID: 15251949
[TBL] [Abstract][Full Text] [Related]
36. A multiplex PCR for non-invasive fetal RHD genotyping using cell-free fetal DNA.
Tounta G; Vrettou C; Kolialexi A; Papantoniou N; Destouni A; Tsangaris GT; Antsaklis A; Kanavakis E; Mavrou A
In Vivo; 2011; 25(3):411-7. PubMed ID: 21576416
[TBL] [Abstract][Full Text] [Related]
37. Rh0(D) and Du cord blood typing during elective abortion operations.
Munsick RA
Obstet Gynecol; 1986 Mar; 67(3):356-7. PubMed ID: 3080717
[TBL] [Abstract][Full Text] [Related]
38. The use of maternal plasma for prenatal RhD blood group genotyping.
Finning K; Martin P; Daniels G
Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
[TBL] [Abstract][Full Text] [Related]
39. Discordance between fetal RhD typing using molecular methods and neonatal typing with serology.
Van Den Veyver IB; Yankowitz J; Subramanian SB; Dorman KF; Moise KJ
Gynecol Obstet Invest; 1999; 48(4):229-31. PubMed ID: 10592422
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive prenatal RhD testing.
Moise KJ
Am J Obstet Gynecol; 2006 Dec; 195(6):e20; author reply e21. PubMed ID: 16545331
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
